SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zenotech Laboratorie reports Profit after tax of Rs 0.71 Mln, in the December 2020 quarter

23 Jan 2021 Evaluate
The sales declined to Rs. 46.43 millions for the December 2020 quarter as compared to Rs. 65.16 millions during the corresponding quarter last year.Net profit was down at Rs. 0.71  millions against Rs. 68.57 millions recorded in the corresponding quarter a year ago.The net profit spiraled down by -98.96%.Operating profit for the quarter ended December 2020 rose to 22.53 millions as compared to 19.77 millions of corresponding quarter ended December 2019.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202012 201912 % Var 202012 201912 % Var 202003 201903 % Var
Sales 46.43 65.16 -28.74 125.40 206.29 -39.21 259.38 130.29 99.08
Other Income 10.35 3.39 205.31 21.24 10.18 108.64 12.53 47.10 -73.40
PBIDT 22.53 19.77 13.96 34.12 87.22 -60.88 101.50 11.93 750.80
Interest 4.69 2.29 104.80 10.89 8.02 35.79 8.93 1.18 656.78
PBDT 17.84 81.18 -78.02 23.23 142.90 -83.74 156.27 10.75 1353.67
Depreciation 17.13 12.61 35.84 47.18 34.76 35.73 48.50 42.02 15.42
PBT 0.71 68.57 -98.96 -23.95 108.14 -122.15 107.77 -31.27 -444.64
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.71 68.57 -98.96 -23.95 108.14 -122.15 107.77 -31.27 -444.64
Equity 610.31 610.31 0.00 610.31 610.31 0.00 610.31 610.31 0.00
PBIDTM(%) 48.52 30.34 59.93 27.21 42.28 -35.65 39.13 9.16 327.37

Zenotech Laboratorie Share Price

47.46 -1.91 (-3.87%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×